Table 1

Results summary: cumulative impact of reducing smoking prevalence, Minnesota 1998–2017

OutcomeConstant prevalence scenarioRealised prevalence scenarioDifference
Youth smoking prevalence,* ages 9–1713.7%4.3%−9.4%
Adult smoking prevalence,* ages 18+23.5%13.5%−10.0%
Person-years of cigarette smoking, all ages19 717 41314 167 908−5 549 505
SA cancers175 533170 974−4560
SA CVD and diabetes hospitalisations1 507 2291 475 538−31 691
SA respiratory disease hospitalisations452 004439 123−12 881
SA deaths186 555182 437−4118
SA medical costs (million US$ of 2017)29 82927 172−2657
Productivity (million US$ of 2017)23 91321 534−2378

  • *Calibrated smoking prevalence in 2017.

  • CVD, cardiovascular disease; SA, smoking-attributable.